rewrite this title TransMedics Stock: Value or Value Trap? – Nanalyze

Never be in any hurry to buy a stock, especially one that everyone on social media can’t stop talking about. Odds are that all the hype creates volatility, and that always goes both ways. The first time we looked at TransMedics $TMDX three years ago they had a simple valuation ratio (SVR) of twenty, somewhere around three times the average of our tech stock catalog. Then last year the SVR dropped to six, right at our catalog average. Today it sits at around 3.5 after a 40% drop in share price this year. So does an investment in TransMedics represent value or a value trap?

The deceleration in growth seen above hints at our biggest concern surrounding the TransMedics thesis. Is the opportunity big enough to keep growth continuing well into the future?

Estimating the TransMedics Opportunity

The secret sauce behind TransMedics is their organ care system (OCS) which takes harvested organs from donors and keeps them well until they’re transplanted into organ donor recipients. By keeping organs (heart, lung, and liver) warm, perfused with oxygenated blood, and beating or functioning outside the body, it effectively expands the pool of viable donors which hints at a blue ocean total addressable market (TAM) that’s not being addressed. That, or the current standard of a box of